- Report
- April 2025
- 50 Pages
Global
From €2417EUR$2,650USD£2,066GBP
Avasimibe is a cholesterol-lowering drug used to treat cardiovascular diseases. It works by inhibiting the enzyme HMG-CoA reductase, which is responsible for the production of cholesterol in the body. Avasimibe is used to reduce the risk of heart attack, stroke, and other cardiovascular events in people with high cholesterol levels. It is also used to reduce the risk of needing a procedure to open blocked heart arteries in people with coronary heart disease. Avasimibe is available in both tablet and capsule form and is usually taken once a day.
Avasimibe is a widely used drug in the cardiovascular market. It is often prescribed in combination with other cholesterol-lowering drugs, such as statins, to help reduce cholesterol levels. Avasimibe is also used in combination with lifestyle changes, such as diet and exercise, to help reduce the risk of cardiovascular events.
Some companies in the Avasimibe market include Merck & Co., Inc., Pfizer, Inc., AstraZeneca, and Bristol-Myers Squibb. Show Less Read more